Human genetic studies have linked numerous neuronal proteins to neurodegenerative disease, but the functions of many of these proteins remain unclear thus hindering the development of effective therapies. In this project, I will apply our newly developed acute protein disruption technique along with advanced optical methods for monitoring neurotransmitter release, so that we may better understand the function of the Parkinson’s disease relevant protein α-synuclein.